Facility

Why Is Norfolk County Selling the Port Rowan Medical
Management & Regulatory Why Is Norfolk County Selling the Port Rowan Medical

The strategic decision by Norfolk County councillors to authorize the sale of the Port Rowan Medical Centre represents a pivotal moment in the municipality's ongoing effort to divest itself from non-essential real estate holdings and focus on core service delivery. Located at 1035 Bay Street, this

Tumor Cell Mapping Predicts Melanoma Treatment Success
Management & Regulatory Tumor Cell Mapping Predicts Melanoma Treatment Success

The recent breakthrough in oncological research has shifted the paradigm from analyzing what a tumor is composed of to understanding exactly how its internal components are physically positioned. Researchers at the UCLA Health Jonsson Comprehensive Cancer Center have identified that the spatial

Can Liquid Biopsies Improve Lung Cancer Care in the UAE?
Management & Regulatory Can Liquid Biopsies Improve Lung Cancer Care in the UAE?

The introduction of precision diagnostic tools into the clinical landscape of the United Arab Emirates represents a significant shift in how healthcare providers manage complex respiratory malignancies. Non-small cell lung cancer continues to be the most prevalent form of the disease globally,

Review of Rezurock GVHD Treatment
Management & Regulatory Review of Rezurock GVHD Treatment

The journey following a stem cell transplant can be fraught with complications, none more debilitating than chronic graft-versus-host disease, a condition where donor immune cells relentlessly attack the recipient's body. This review assesses Rezurock (belumosudil) as a critical therapeutic option

Biogen Lupus Drug Earns FDA Breakthrough Designation
Management & Regulatory Biogen Lupus Drug Earns FDA Breakthrough Designation

For individuals grappling with the relentless and often disfiguring effects of cutaneous lupus erythematosus, the path to effective treatment has been long and fraught with limited options, but a significant development from Biogen offers a new beacon of hope. The U.S. Food and Drug Administration

AstraZeneca's $2B Maryland Expansion Boosts US Biologics
Biotech & Bioprocessing AstraZeneca's $2B Maryland Expansion Boosts US Biologics

In an era where supply chain resilience and access to life-saving therapies dominate healthcare discussions, AstraZeneca's announcement of a $2 billion investment in Maryland facilities has captured significant attention, raising critical questions about domestic production. This ambitious

Loading

Subscribe to our weekly news digest.

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later